Molton SA - Search Results

1

Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited.

Molton SA, Todd DE, Cook SJ. Molton SA, et al. Oncogene. 2003 Jul 24;22(30):4690-701. doi: 10.1038/sj.onc.1206692. Oncogene. 2003. PMID: 12879014

2

Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways.

Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R, Wagner EF, Cook SJ. Weston CR, et al. Among authors: molton sa. Oncogene. 2003 Mar 6;22(9):1281-93. doi: 10.1038/sj.onc.1206261. Oncogene. 2003. PMID: 12618753

3

ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest.

Todd DE, Densham RM, Molton SA, Balmanno K, Newson C, Weston CR, Garner AP, Scott L, Cook SJ. Todd DE, et al. Among authors: molton sa. Oncogene. 2004 Apr 22;23(19):3284-95. doi: 10.1038/sj.onc.1207467. Oncogene. 2004. PMID: 14981547

4

The conditional kinase DeltaMEKK1:ER* selectively activates the JNK pathway and protects against serum withdrawal-induced cell death.

Molton SA, Weston C, Balmanno K, Newson C, Todd DE, Garner AP, Cook SJ. Molton SA, et al. Cell Signal. 2005 Nov;17(11):1412-22. doi: 10.1016/j.cellsig.2005.02.006. Cell Signal. 2005. PMID: 15893455

5

Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.

Liu J, Suresh Kumar KG, Yu D, Molton SA, McMahon M, Herlyn M, Thomas-Tikhonenko A, Fuchs SY. Liu J, et al. Among authors: molton sa. Oncogene. 2007 Mar 22;26(13):1954-8. doi: 10.1038/sj.onc.1209994. Epub 2006 Sep 25. Oncogene. 2007. PMID: 17001349 Free PMC article.

6

Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.

McCubrey JA, Abrams SL, Ligresti G, Misaghian N, Wong EW, Steelman LS, Bäsecke J, Troppmair J, Libra M, Nicoletti F, Molton S, McMahon M, Evangelisti C, Martelli AM. McCubrey JA, et al. Leukemia. 2008 Nov;22(11):2080-90. doi: 10.1038/leu.2008.207. Epub 2008 Aug 7. Leukemia. 2008. PMID: 18685611

7

Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.

Cartlidge RA, Thomas GR, Cagnol S, Jong KA, Molton SA, Finch AJ, McMahon M. Cartlidge RA, et al. Among authors: molton sa. Pigment Cell Melanoma Res. 2008 Oct;21(5):534-44. doi: 10.1111/j.1755-148X.2008.00491.x. Epub 2007 Jul 28. Pigment Cell Melanoma Res. 2008. PMID: 18715233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters